Several mechanisms, including immobilisation, rise in circulating inflammatory substances and unbalance of the RANKL/osteoprotegerin system, have been suggested to be at least in part responsible for the resorption of bone and subsequent hypercalcemia in these patients [30,31,32]. This evidence concerns the gene TNFSF11 and hypercalcemia disease.